An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells

Cancer Cell

Volumn 6, Issue 5, 2004, Pages 497-506

  Bafico, Anna ^a   Liu, Guizhong ^a   Goldin, Luba ^a   Harris, Violaine ^a   Aaronson, Stuart A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WNT PROTEIN;

ARTICLE; AUTOCRINE EFFECT; BIOTRANSFORMATION; CANCER CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; UPREGULATION;

MOUSE MAMMARY TUMOR VIRUS;

EID: 7944230668     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.09.032     Document Type: Article

References (83)

1. Alonso L., Fuchs E. Stem cells in the skin. Waste not, Wnt not Genes Dev. 17:2003;1189-1200
2. th edition:2003;53-71 BC Decker, Hamilton, Ontario
3. Bafico A., Gazit A., Wu-Morgan S.S., Yaniv A., Aaronson S.A. Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts. Oncogene. 16:1998;2819-2825
4. Bafico A., Gazit A., Pramila T., Finch P.W., Yaniv A., Aaronson S.A. Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J. Biol. Chem. 274:1999;16180-16187
5. Bafico A., Liu G., Yaniv A., Gazit A., Aaronson S.A. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat. Cell Biol. 3:2001;683-686
6. Bejcek B.E., Li D.Y., Deuel T.F. Transformation by v-sis occurs by an internal autoactivation mechanism. Science. 245:1989;1496-1499
7. Bienz M., Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 103:2000;311-320
8. Blasband A., Schryver B., Papkoff J. The biochemical properties and transforming potential of human Wnt-2 are similar to Wnt-1. Oncogene. 7:1992;153-161
9. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature. 411:2001;355-365
10. Brown A.M. Wnt signaling in breast cancer. Have we come full circle? Breast Cancer Res. 3:2001;351-355
11. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553
12. Bui T.D., Rankin J., Smith K., Huguet E.L., Ruben S., Strachan T., Harris A.L., Lindsay S. A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene. 14:1997;1249-1253
13. Cadigan K.M., Nusse R. Wnt signaling. A common theme in animal development Genes Dev. 11:1997;3286-3305
14. Caldwell G.M., Jones C., Gensberg K., Jan S., Hardy R.G., Byrd P., Chughtai S., Wallis Y., Matthews G.M., Morton D.G. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res. 64:2004;883-888
15. Chan T.A., Wang Z., Dang L.H., Vogelstein B., Kinzler K.W. Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation. Proc. Natl. Acad. Sci. USA. 99:2002;8265-8270
16. Chen S., Guttridge D.C., You Z., Zhang Z., Fribley A., Mayo M.W., Kitajewski J., Wang C.Y. Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription. J. Cell Biol. 152:2001;87-96
17. Dale T.C., Weber-Hall S.J., Smith K., Huguet E.L., Jayatilake H., Gusterson B.A., Shuttleworth G., O'Hare M., Harris A.L. Compartment switching of WNT-2 expression in human breast tumors. Cancer Res. 56:1996;4320-4323
18. Doolittle R.F., Hunkapiller M.W., Hood L.E., Devare S.G., Robbins K.C., Aaronson S.A., Antoniades H.N. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 221:1983;275-277
19. Fedi P., Bafico A., Nieto Soria A., Burgess W.H., Miki T., Bottaro D.P., Kraus M.H., Aaronson S.A. Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J. Biol. Chem. 274:1999;19465-19472
20. Filali M., Cheng N., Abbott D., Leontiev V., Engelhardt J.F. Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter. J. Biol. Chem. 277:2002;33398-33410
21. Finch P.W., He X., Kelley M.J., Uren A., Schaudies R.P., Popescu N.C., Rudikoff S., Aaronson S.A., Varmus H.E., Rubin J.S. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc. Natl. Acad. Sci. USA. 94:1997;6770-6775
22. Giles R.H., van Es J.H., Clevers H. Caught up in a Wnt storm. Wnt signaling in cancer Biochim. Biophys. Acta. 1653:2003;1-24
23. Glinka A., Wu W., Delius H., Monaghan A.P., Blumenstock C., Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 391:1998;357-362
24. Going J.J. Stages on the way to breast cancer. J. Pathol. 199:2003;1-3
25. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512
26. Huang J.S., Huang S.S., Deuel T.F. Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors. Cell. 39:1984;79-87
27. Hudziak R.M., Lewis G.D., Winget M., Fendly B.M., Shepard H.M., Ullrich A. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell. Biol. 9:1989;1165-1172
28. Huguet E.L., McMahon J.A., McMahon A.P., Bicknell R., Harris A.L. Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res. 54:1994;2615-2621
29. Hulsken J., Birchmeier W., Behrens J. E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton. J. Cell Biol. 127:1994;2061-2069
30. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 116:2003;2627-2634
31. Keating M.T., Williams L.T. Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science. 239:1988;914-916
32. Kuhnert F., Davis C.R., Wang H.T., Chu P., Lee M., Yuan J., Nusse R., Kuo C.J. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc. Natl. Acad. Sci. USA. 101:2004;266-271
33. Lee B.A., Donoghue D.J. Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction. J. Cell Biol. 118:1992;1057-1070
34. Lepourcelet M., Chen Y.N., France D.S., Wang H., Crews P., Petersen F., Bruseo C., Wood A.W., Shivdasani R.A. Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex. Cancer Cell. 5:2004;91-102
35. Leyns L., Bouwmeester T., Kim S.H., Piccolo S., De Robertis E.M. Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell. 88:1997;747-756
36. Li Y., Welm B., Podsypanina K., Huang S., Chamorro M., Zhang X., Rowlands T., Egeblad M., Cowin P., Werb Z., et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc. Natl. Acad. Sci. USA. 100:2003;15853-15858
37. Lin K., Wang S., Julius M.A., Kitajewski J., Moos M. Jr., Luyten F.P. The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc. Natl. Acad. Sci. USA. 94:1997;11196-11200
38. Lin S.Y., Xia W., Wang J.C., Kwong K.Y., Spohn B., Wen Y., Pestell R.G., Hung M.C. β-catenin, a novel prognostic marker for breast cancer. its roles in cyclin D1 expression and cancer progression Proc. Natl. Acad. Sci. USA. 97:2000;4262-4266
39. Liu G., Bafico A., Harris V.K., Aaronson S.A. A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. Mol. Cell. Biol. 23:2003;5825-5835
40. Liu B.Y., McDermott S.P., Khwaja S.S., Alexander C.M. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc. Natl. Acad. Sci. USA. 101:2004;4158-4163
41. Longo K.A., Kennell J.A., Ochocinska M.J., Ross S.E., Wright W.S., MacDougald O.A. Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J. Biol. Chem. 277:2002;38239-38244
42. Macip S., Igarashi M., Berggren P., Yu J., Lee S.W., Aaronson S.A. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 23:2003;8576-8585
43. Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., Niehrs C. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature. 411:2001;321-325
44. Mao B., Wu W., Davidson G., Marhold J., Li M., Mechler B.M., Delius H., Hoppe D., Stannek P., Walter C., et al. Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling. Nature. 417:2002;664-667
45. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science. 275:1997;1787-1790
46. Myers C., Cooper M., Stein C., LaRocca R., Walther M.M., Weiss G., Choyke P., Dawson N., Steinberg S., Uhrich M.M., et al. Suramin. A novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer J. Clin. Oncol. 10:1992;881-889
47. Nusse R., Varmus H.E. Wnt genes. Cell. 69:1992;1073-1087
48. Orford K., Orford C.C., Byers S.W. Exogenous expression of β-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J. Cell Biol. 146:1999;855-868
49. Palacios J., Gamallo C. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res. 58:1998;1344-1347
50. Pierce J.H., Arnstein P., DiMarco E., Artrip J., Kraus M.H., Lonardo F., Di Fiore P.P., Aaronson S.A. Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene. 6:1991;1189-1194
51. Pinson K.I., Brennan J., Monkley S., Avery B.J., Skarnes W.C. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature. 407:2000;535-538
52. Pinto D., Gregorieff A., Begthel H., Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 17:2003;1709-1713
53. Polakis P. Wnt signaling and cancer. Genes Dev. 14:2000;1837-1851
54. Polesskaya A., Seale P., Rudnicki M.A. Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell. 113:2003;841-852
55. Rattner A., Hsieh J.C., Smallwood P.M., Gilbert D.J., Copeland N.G., Jenkins N.A., Nathans J. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc. Natl. Acad. Sci. USA. 94:1997;2859-2863
56. Reya T., Duncan A.W., Ailles L., Domen J., Scherer D.C., Willert K., Hintz L., Nusse R., Weissman I.L. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 423:2003;409-414
57. Rockman S.P., Currie S.A., Ciavarella M., Vincan E., Dow C., Thomas R.J., Phillips W.A. Id2 is a target of the β-catenin/T cell factor pathway in colon carcinoma. J. Biol. Chem. 276:2001;45113-45119
58. Rowlands T.M., Pechenkina I.V., Hatsell S.J., Pestell R.G., Cowin P. Dissecting the roles of β-catenin and cyclin D1 during mammary development and neoplasia. Proc. Natl. Acad. Sci. USA. 100:2003;11400-11405
59. Sagae S., Kobayashi K., Nishioka Y., Sugimura M., Ishioka S., Nagata M., Terasawa K., Tokino T., Kudo R. Mutational analysis of β-catenin gene in Japanese ovarian carcinomas. Frequent mutations in endometrioid carcinomas Jpn. J. Cancer Res. 90:1999;510-515
60. Sekine S., Shibata T., Sakamoto M., Hirohashi S. Target disruption of the mutant β-catenin gene in colon cancer cell line HCT116. preservation of its malignant phenotype Oncogene. 21:2002;5906-5911
61. Semenov M.V., Tamai K., Brott B.K., Kuhl M., Sokol S., He X. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr. Biol. 11:2001;951-961
62. Shimizu H., Julius M.A., Giarre M., Zheng Z., Brown A.M., Kitajewski J. Transformation by Wnt family proteins correlates with regulation of β-catenin. Cell Growth Differ. 8:1997;1349-1358
63. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA. 96:1999;5522-5527
64. Siu I.M., Robinson D.R., Schwartz S., Kung H.J., Pretlow T.G., Petersen R.B., Pretlow T.P. The identification of monoclonality in human aberrant crypt foci. Cancer Res. 59:1999;63-66
65. Slamon D.J., Leyland-Jones B., Shak S., Fuchs H., Paton V., Bajamonde A., Fleming T., Eiermann W., Wolter J., Pegram M., et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344:2001;783-792
66. Staal F.J., Noort Mv M., Strous G.J., Clevers H.C. Wnt signals are transmitted through N-terminally dephosphorylated β-catenin. EMBO Rep. 3:2002;63-68
67. Stampfer M.R., Bartley J.C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc. Natl. Acad. Sci. USA. 82:1985;2394-2398
68. Stingl J., Eaves C.J., Zandieh I., Emerman J.T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. 67:2001;93-109
69. Sugrue M.M., Shin D.Y., Lee S.W., Aaronson S.A. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA. 94:1997;9648-9653
70. Suzuki H., Gabrielson E., Chen W., Anbazhagan R., van Engeland M., Weijenberg M.P., Herman J.G., Baylin S.B. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31:2002;141-149
71. Suzuki H., Watkins D.N., Jair K.W., Schuebel K.E., Markowitz S.D., Dong Chen W., Pretlow T.P., Yang B., Akiyama Y., Van Engeland M., et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 36:2004;417-422
72. Tetsu O., McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426
73. van de Wetering M., de Lau W., Clevers H. WNT signaling and lymphocyte development. Cell. 109(Suppl):2002;S13-S19. a
74. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 111:2002;241-250. b
75. van Noort M., Meeldijk J., van der Zee R., Destree O., Clevers H. Wnt signaling controls the phosphorylation status of β-catenin. J. Biol. Chem. 277:2002;17901-17905
76. Wang S., Krinks M., Lin K., Luyten F.P., Moos M. Jr. Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell. 88:1997;757-766
77. Waterfield M.D., Scrace G.T., Whittle N., Stroobant P., Johnsson A., Wasteson A., Westermark B., Heldin C.H., Huang J.S., Deuel T.F. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature. 304:1983;35-39
78. Wehrli M., Dougan S.T., Caldwell K., O'Keefe L., Schwartz S., Vaizel-Ohayon D., Schejter E., Tomlinson A., DiNardo S. arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature. 407:2000;527-530
79. Wiley H.S., Woolf M.F., Opresko L.K., Burke P.M., Will B., Morgan J.R., Lauffenburger D.A. Removal of the membrane-anchoring domain of epidermal growth factor leads to intracrine signaling and disruption of mammary epithelial cell organization. J. Cell Biol. 143:1998;1317-1328
80. Wong G.T., Gavin B.J., McMahon A.P. Differential transformation of mammary epithelial cells by Wnt genes. Mol. Cell. Biol. 14:1994;6278-6286
81. Wu R., Zhai Y., Fearon E.R., Cho K.R. Diverse mechanisms of β-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res. 61:2001;8247-8255
82. You Z., Saims D., Chen S., Zhang Z., Guttridge D.C., Guan K.L., MacDougald O.A., Brown A.M., Evan G., Kitajewski J., Wang C.Y. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J. Cell Biol. 157:2002;429-440
83. Yu Q., Geng Y., Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature. 411:2001;1017-1021